These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37301536)

  • 1. FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.
    Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
    Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression.
    Tian X; Dai S; Sun J; Jin G; Jiang S; Meng F; Li Y; Wu D; Jiang Y
    Oncotarget; 2015 Sep; 6(26):22767-75. PubMed ID: 26087183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
    Guo F; Liu J; Han X; Zhang X; Lin T; Wang Y; Bai J; Han J
    Int J Biol Sci; 2019; 15(3):647-656. PubMed ID: 30745851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fbxo22 promotes cervical cancer progression via targeting p57
    Lin M; Zhang J; Bouamar H; Wang Z; Sun LZ; Zhu X
    Cell Death Dis; 2022 Sep; 13(9):805. PubMed ID: 36127346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXO22, an epigenetic multiplayer coordinating senescence, hormone signaling, and metastasis.
    Johmura Y; Harris AS; Ohta T; Nakanishi M
    Cancer Sci; 2020 Aug; 111(8):2718-2725. PubMed ID: 32536008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
    Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
    Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FBXO22, ubiquitination degradation of PHLPP1, ameliorates rotenone induced neurotoxicity by activating AKT pathway.
    Zheng X; Yu S; Xue Y; Yan F
    Toxicol Lett; 2021 Oct; 350():1-9. PubMed ID: 34182063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCF
    Bai J; Wu K; Cao MH; Yang Y; Pan Y; Liu H; He Y; Itahana Y; Huang L; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11754-11763. PubMed ID: 31138683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
    Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
    Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.
    Dikopoltsev E; Foltyn VN; Zehl M; Jensen ON; Mori H; Radzishevsky I; Wolosker H
    J Biol Chem; 2014 Dec; 289(49):33904-15. PubMed ID: 25336657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of KDM5A and regulation of H3K4me3 demethylation.
    Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
    Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.
    De S; Holvey-Bates EG; Mahen K; Willard B; Stark GR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
    Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
    J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.
    Jiang J; Bai J; Qin T; Wang Z; Han L
    J Cell Mol Med; 2020 May; 24(10):5901-5910. PubMed ID: 32294802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis.
    Suzuki N; Johmura Y; Wang TW; Migita T; Wu W; Noguchi R; Yamaguchi K; Furukawa Y; Nakamura S; Miyoshi I; Yoshimori T; Ohta T; Nakanishi M
    Autophagy; 2021 Nov; 17(11):3776-3793. PubMed ID: 33706682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Li S; Shi L; Wang Y; Zhang L; Chu S; Li M; Bai J; Zhu W
    Exp Cell Res; 2023 Sep; 430(1):113719. PubMed ID: 37442264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression.
    Sun R; Xie HY; Qian JX; Huang YN; Yang F; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2018 Sep; 78(18):5274-5286. PubMed ID: 29945959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.